The global endoscopy devices market was valued at USD 61.06 billion in 2024 and is projected to expand at a Compound Annual Growth Rate (CAGR) of 3.79% from 2025 to 2030. Several factors are expected to propel this growth, particularly the increasing preference for minimally invasive procedures that offer less recovery time and reduced risk of complications. Endoscopy devices are seen as a more cost-effective option, both in terms of pre-procedure and post-procedure costs. The adoption of disposable components for endoscopic procedures to reduce the risk of cross-contamination and minimize the overall cost of the procedures is also anticipated to play a significant role in accelerating market growth over the forecast period.

Technological advancements continue to be a crucial driver of the endoscopy devices market. Manufacturers are consistently innovating new endoscopic solutions to improve the quality of diagnosis and treatment, particularly for chronic conditions. For example, in August 2021, Fujifilm Holdings Corporation introduced the ELUXEO 7000X endoscopic imaging system. This cutting-edge system enables real-time monitoring of hemoglobin oxygen saturation (StO2) levels during laparoscopic and endoluminal imaging procedures, representing the significant strides being made in endoscopic technology.

Gather more insights about the market drivers, restrains and growth of the Endoscopy Devices Market

Regional Insights

North America:

The North American endoscopy devices market is the largest globally, accounting for 39.8% of the revenue share in 2024. The market's dominance is attributed to the high prevalence of various diseases, including gastrointestinal (GI) disorders, respiratory issues, urological conditions, gynecological problems, and cancer. For instance, ResearchGate projects that in 2024, the U.S. will witness 2.0 million new cancer cases, with 611,720 cancer-related deaths, thus driving the demand for accurate diagnostic and therapeutic tools like endoscopes. This trend is further fueled by the increasing preference for minimally invasive diagnostic and treatment methods across medical specialties, including gastroenterology, pulmonology, urology, gynecology, and otolaryngology.

US:

The U.S. market is the largest within North America, driven by rising demand for minimally invasive surgeries and the growing prevalence of cancer and chronic diseases. The aging population, particularly those over 65 years old who are more prone to chronic illnesses requiring endoscopic procedures, is further propelling the market. For instance, the American Cancer Society anticipates that 26,890 new cases of stomach cancer and 10,880 related deaths will be reported in 2024. The demand for early and accurate diagnosis, coupled with the ongoing healthcare system shifts toward less invasive treatments, further accelerates the adoption of endoscopy devices.

Canada:

Canada's endoscopy devices market is set to experience the fastest growth over the forecast period. Recent advancements in endoscopy surgery, especially in the treatment of GI tract disorders, are expected to significantly impact the market. The preference for minimally invasive surgeries—thanks to faster recovery, fewer complications, and better precision—is increasing. Additionally, endoscopic ear surgery has gained considerable traction in Canada following approval from the UBC Behavioral Research Ethics Board, driving further demand for endoscopes.

Europe:

Europe is poised to register significant growth in the endoscopy devices market. Ongoing technological advancements and the rising demand for minimally invasive procedures are expected to boost the market. Favorable economic conditions in Europe are motivating key industry players to explore new market strategies, including mergers, acquisitions, and technological collaborations to enhance their market presence. For instance, in June 2023, Pentax Medical introduced the Inspira premium video processor and the i20c video endoscope series in Dublin, reflecting the growing focus on innovative product launches.

Germany:

Germany's endoscopy devices market is set to witness considerable growth, driven by the high prevalence of chronic diseases and the rising awareness about disposable endoscopic components. Germany's aging population, with a large segment over 65 years old (18.6 million individuals, including 6.1 million aged 80 or older), is expected to contribute to market growth. Additionally, the 46% of adults in Germany who report at least one chronic health condition, as per an NCBI report published in February 2024, are fueling the demand for diagnostic and therapeutic endoscopic procedures.

UK:

In the UK, the endoscopy devices market is also expected to register considerable growth. The market is largely driven by the high prevalence of cancer and chronic diseases, along with the growing geriatric population. According to Macmillan Cancer Support, in 2022, around 3 million cancer patients were reported, and by 2040, 5.3 million cancer diagnoses are projected. The National Awareness and Early Diagnosis Initiative, which aims to provide earlier cancer diagnosis and better treatment access, is playing a significant role in driving the adoption of endoscopes in the UK.

Asia Pacific:

The Asia Pacific region is anticipated to be the fastest-growing market for endoscopy devices, thanks to rapid improvements in healthcare infrastructure, less stringent regulatory environments, and economic development that is attracting foreign investments. Key industry players are actively expanding their presence in this region, supported by private players investing in initiatives such as training healthcare professionals and increasing research and development (R&D) investments for the development of advanced endoscopes.

China:

China holds the largest share of the endoscopy devices market in Asia. As the world’s most populous country and one of the fastest-growing economies, China is witnessing a surge in the adoption of advanced endoscopic solutions. In July 2023, a collaboration between HOYA Group and PENTAX Medical led to the establishment of a new manufacturing and R&D facility in Shanghai, aimed at producing endoscopes tailored to the Chinese market. Such initiatives are expected to further boost demand in the country, driven by rising healthcare expenditure and a growing elderly population.

India:

India’s endoscopy devices market is also expected to grow significantly. The market is driven by increasing preference for minimally invasive surgeries, the rise of chronic diseases, and favorable reimbursement plans offered by private insurance companies. The availability of cancer screening programs is further contributing to market growth. With a rapidly growing middle class and rising disposable income, India is seeing a higher demand for advanced medical technologies, including endoscopes.

Latin America:

Latin America’s endoscopy devices market is expected to experience considerable growth. The increasing preference for minimally invasive surgeries over traditional open surgeries, along with growing awareness about the benefits of endoscopy for diagnostic and therapeutic procedures, is expected to drive the market. The fragmented distribution network in Latin America, with multiple small companies offering easy access to endoscopy devices, further supports the region's growth.

Brazil:

Brazil, as the largest economy in Latin America, is expected to drive the regional market. The increasing geriatric population and rising prevalence of chronic diseases such as GI disorders, gynecological problems, and cancer are significant contributors to market growth. According to the GVR Internal Database, Brazil reported 469,925 cases of breast cancer in 2023, which is expected to fuel demand for diagnostic endoscopic procedures.

Middle East and Africa (MEA):

MEA is expected to be one of the fastest-growing regions for endoscopy devices during the forecast period. The increase in the geriatric population, the rising prevalence of cancer, and the growing demand for early disease diagnosis are key factors driving the market. Additionally, government initiatives to improve healthcare coverage and high per capita disposable income in the region are further promoting the adoption of advanced medical technologies, including endoscopes. As the Gulf Cooperation Council (GCC) region develops rapidly, it is expected to boost the growth of technologically advanced medical devices.

South Africa:

In South Africa, the endoscopy devices market is experiencing rapid growth due to its well-established healthcare infrastructure, which focuses on providing advanced medical services and technologies. The demand for accurate diagnoses and minimally invasive treatments is driving the need for endoscopes. Additionally, the rising number of colonoscopy procedures and bacterial infections is expected to drive the demand for disposable endoscopes, further enhancing market growth.

Browse through Grand View Research's Medical Devices Industry Research Reports.

• The global optical preclinical imaging market size was estimated at USD 620.7 million in 2024 and is projected to grow at a CAGR of 4.2% from 2025 to 2030. 

• The global medical washer disinfector market size was estimated at USD 2,005.88 million in 2024 and is projected to grow at a CAGR of 6.11% from 2025 to 2030. 

Key Endoscopy Devices Companies:

The following are the leading companies in the endoscopy devices market. These companies collectively hold the largest market share and dictate industry trends.

• Olympus Corporation
• Boston Scientific Corporation
• PENTAX Medical (Hoya Corporation)
• FUJIFILM Holdings Corporation
• Karl Storz GmbH & Co., KG
• Stryker
• Medtronic
• Ambu A/S

Order a free sample PDF of the Endoscopy Devices Market Intelligence Study, published by Grand View Research.